Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2008-12-16
pubmed:abstractText
So far only the detection of 14-3-3 proteins in cerebrospinal fluid (CSF) is included in the diagnostic criteria for sporadic Creutzfeldt-Jakob disease (sCJD). However, this assay cannot be used for screening because of the high rate of false positive results in sCJD, and often negative results in variant CJD. To facilitate the differential diagnosis of CJD, we applied 2-D differential gel-electrophoresis (2-D DIGE) as a quantitative proteomic screening system for CSF proteins. We compared 36 patients suffering from sCJD with 30 patients suffering from other neurodegenerative diseases. Sample preparation was optimized in consideration of the fact that CSF is composed of blood- and brain-derived proteins, and an improved 2-D DIGE protocol was established. Using this method in combination with protein identification by MALDI-TOF-MS, several known surrogate markers of sCJD like 14-3-3 protein, neuron-specific enolase, and lactate dehydrogenase were readily identified. Moreover, a not yet identified protein with an approximate molecular mass of 85 kDa was found as marker for sCJD with high diagnostic specificity and sensitivity. We conclude that our proteomic approach is useful to differentiate CJD from other neurodegenerative diseases and expect that CSF-optimized 2-D DIGE will find broad application in the search for other brain derived proteins in CSF.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1615-9861
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4357-66
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18814332-14-3-3 Proteins, pubmed-meshheading:18814332-Aged, pubmed-meshheading:18814332-Aged, 80 and over, pubmed-meshheading:18814332-Alzheimer Disease, pubmed-meshheading:18814332-Biological Markers, pubmed-meshheading:18814332-Creutzfeldt-Jakob Syndrome, pubmed-meshheading:18814332-Diagnosis, Differential, pubmed-meshheading:18814332-Electrophoresis, Gel, Two-Dimensional, pubmed-meshheading:18814332-Female, pubmed-meshheading:18814332-Gelsolin, pubmed-meshheading:18814332-Humans, pubmed-meshheading:18814332-Lewy Body Disease, pubmed-meshheading:18814332-Male, pubmed-meshheading:18814332-Middle Aged, pubmed-meshheading:18814332-Neurodegenerative Diseases, pubmed-meshheading:18814332-Prealbumin, pubmed-meshheading:18814332-Spectrometry, Mass, Matrix-Assisted Laser..., pubmed-meshheading:18814332-Transferrin, pubmed-meshheading:18814332-tau Proteins
pubmed:year
2008
pubmed:articleTitle
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
pubmed:affiliation
Department of Neurodegeneration and Restorative Research, Center of Neurological Medicine, University of Goettingen, Goettingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Validation Studies